Cutler Group LP Corcept Therapeutics Inc Put Options Transaction History

Cutler Group LP

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2020 Jan 21, 2021	SELL	$16.78 - $27.3 $25,170 - $40,950	-1,500 Closed	0 $0
Q3 2020 Oct 27, 2020	BUY	$12.46 - $19.98 $18,690 - $29,970	1,500 New	1,500 $0
Q1 2019 May 10, 2019	SELL	$10.03 - $15.71 $80,240 - $125,680	-8,000 Closed	0 $0
Q4 2018 Feb 05, 2019	BUY	$11.29 - $17.19 $90,320 - $137,520	8,000 New	8,000 $21,000
Q3 2018 Nov 07, 2018	SELL	$12.27 - $15.65 $63,804 - $81,380	-5,200 Closed	0 $0
Q2 2018 Aug 10, 2018	BUY	$15.3 - $19.69 $76,500 - $98,450	5,000 Added 2500.0%	5,200 $16,000
Q4 2017 Jan 17, 2018	BUY	$15.77 - $20.72 $3,154 - $4,144	200	200 $0

347

86.6M

1.12M

667K

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $6.3B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.